In which Sam, Richard and Gaby talk about the new long-acting injectable PrEP agent, cabotegravir - reviewing efficacy, side effects and how this all fits into a larger landscape of HIV prevention and equity.
Read More
In which Sam, Richard and Gaby talk about the history of pre-exposure prophylaxis (PrEP) for HIV, review who PrEP might benefit, and compare the two FDA-approved PrEP options (Descovy and Truvada).
Read More